Co-Diagnostics
$12.509876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$12.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.66 (+5.29%) Today
-$0.64 (-4.87%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Co-Diagnostics and other stocks, options, and ETFs commission-free!
About CODX
Co-Diagnostics, Inc. engages in the development, manufacture, and marketing of diagnostics technology. It offers design services, vector control, equipment, diagnostic, and research solutions. The company was founded by Brent C. Satterfield and Dwight H. Egan on April 18, 2013 and is headquartered in Salt Lake City, UT. The listed name for CODX is Co-Diagnostics, Inc. Common Stock.
CEO
Dwight Howard Egan
Employees
23
Headquarters
Salt Lake City, Utah
Founded
2013
Market Cap
364.69M
Price-Earnings Ratio
13.43
Dividend Yield
—
Average Volume
1.73M
High Today
$13.73
Low Today
$12.15
Open Price
$12.43
Volume
2.66M
52 Week High
$30.99
52 Week Low
$2.06
Collections
CODX Earnings
-$0.10
$0.14
$0.39
$0.63
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 30, After Hours